Key PointsMedtronic had another solid quarter, with FCF expanding to support healthy dividend growth. The guidance is favorable and includes another year of steady, stable growth. Analysts Hold this stock and see it trading near the low end of the expected range with a possible 15% upside. 5 stocks we like better than MedtronicShares of Medtronic NYSE: MDT are falling following its FQ4 release and guidance, opening up a potential buying opportunity. The question is whether its value, yield, balance sheet an ...